... ais01~731!(17Pl 2&4-3 Lldtl. L o.. OC-cnnd, M., & V#ldtn8tf9.A.(2010), ~ f\04ont b' Po i ~ ~ : Clinie:al ...
... signaling pathway ___,,,,,,, 82 ng,'ml (00 dose regimen) 5-4.04 ng/ml (80 OOH: reglfMf'I) ~ ng hrtmt. (ac ...
... > doH, regirMn) ~~~ --~- (~~~~~ 1ll \ Increased depression and anxiety 2M7 nghrfmt (e0 dose regimen) / 0 ...
... : Currene~ es .rod Novel Onig Devel09fl1enl CHS 3 C2()20). Increased Inhibition o l K@.t o-ffdi...ction ...
... pathway .__.-,/ 3 U'kg (baSM Oft a hfftthy indMdual) No eviOtnce showing PKreltted
more >>
Creator:
Orr, Ashley, Hum, Julia, and Fakih, Samar
Description:
Brexanolone (ZULRESSO ™) is a novel approach to treat postpartum depression in adult women as a neuroactive steroid similar in chemical composition to the hormone allopregnanolone. It was approved for use in adult women...
Type:
Poster